ArticleFrontiers in immunology2026

Upadacitinib for atopic dermatitis induced by secukinumab in patients with refractory ankylosing spondylitis:a case report.

Jinxia Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.